Idhifa (Celgene Corporation)
Welcome to the PulseAid listing for the Idhifa drug offered from Celgene Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Celgene Corporation |
NON-PROPRIETARY NAME: | enasidenib mesylate |
SUBSTANCE NAME: | ENASIDENIB MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-08-01 |
END MARKETING DATE: | 0000-00-00 |
Idhifa HUMAN PRESCRIPTION DRUG Details:
Item Description | Idhifa from Celgene Corporation |
LABELER NAME: | Celgene Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2017-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59572-705_6cd3975b-7970-4c9a-a5e5-f0510bf0d770 |
PRODUCT NDC: | 59572-705 |
APPLICATION NUMBER: | NDA209606 |
Other ENASIDENIB MESYLATE Pharmaceutical Manufacturers / Labelers: